Latest MRSA Stories

CHAPEL HILL, N.C., Sept. 9 /PRNewswire/ -- Cempra Pharmaceuticals today announced its schedule of 16 poster presentations at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, Mass., on September 12-15, 2010. Cempra's posters will present data on its oral anti-MRSA antibiotic, TAKSTA (sodium fusidate, or CEM-102), and on its novel fluoroketolide antibiotic, solithromycin (CEM-101). The posters on TAKSTA will present data that include Phase 2 study...

CHAPEL HILL, N.C., Sept. 9 /PRNewswire/ -- Cempra Pharmaceuticals today announced abstracts to be presented on its oral anti-MRSA antibiotic, TAKSTA (sodium fusidate, formerly CEM-102), at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 12 to 15, 2010, in Boston. Data to be presented demonstrate that TAKSTA showed clinical success rates and tolerability comparable to oral linezolid. Presentations will also provide additional data that...

CHICAGO, Aug. 17 /PRNewswire-USNewswire/ -- MRSA Survivors Network, the Chicago-based nonprofit organization, launches their second annual World MRSA Day kick-off event at Loyola University Chicago on October 1, 2010. The 2010 global theme for World MRSA Day is: 'The MRSA Epidemic - A Call to Action.' Other events are planned in the United States, U.K. and Canada throughout the month of October, World MRSA Awareness Month. (Logo; http://photos.prnewswire.com/prnh/20090825/DC65136LOGO )...

WALTHAM, Mass., June 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the uptake of two emerging agents from Forest/AstraZeneca/Takeda and Trius will drive the methicillin-resistant Staphylococcus aureus (MRSA) drug market to increase from $631 million in 2009 to $752 million in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The Pharmacor 2010 findings...

An outbreak of infection due to linezolid and methicillin-resistant StaphylococcuS aureus (LRSA) in 12 intensive care unit patients in Spain was associated with transmission within the hospital and extensive usage of the antibiotic linezolid, often used for the treatment of serious infections, with reductions in linezolid use and infection-control measures associated with resolution of the outbreak, according to a study in the June 9 issue of JAMA.Methicillin-resistant StaphylococcuS aureus...

A study recently published has found that the number of children hospitalized with dangerous drug-resistant staph infections surged 10-fold in recent years. The study showed that disease incidence increased from 2 cases to 21 cases per 1,000 hospital admissions from 1999 to 2008.  Most of the infections were caught in the community, not in the hospital. The study involved methicillin-resistant infections, called MRSA.  These used to occur more often in hospitals and nursing homes, but...

CHICAGO, May 11 /PRNewswire-USNewswire/ -- More Americans die annually from invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than from HIV/AIDS, H1N1 influenza and Parkinson's disease, yet the United States and many other countries' health officials continue to ignore the global crisis. (Logo: http://www.newscom.com/cgi-bin/prnh/20090825/DC65136LOGO) "Everyone knows someone who has been affected by MRSA," states founder Jeanine Thomas, a survivor of MRSA, sepsis and...

HIV-infected patients are at a markedly increased risk for community acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) infections according to a new study by researchers at John H. Stroger, Jr. Hospital of Cook County and Rush University Medical Center.The study, published in the April 1 issue of the journal Clinical Infectious Diseases, found the incidence of CA-MRSA in the Chicago area was six-fold higher among HIV-infected patients than it was among HIV-negative patients.MRSA...

Bathing trauma patients daily using cloths containing the antiseptic chlorhexidine may be associated with a decreased rate of colonization and infection by methicillin-resistant Staphylococcus aureus (MRSA) and other difficult-to-treat bacteria, according to a report in the March issue of Archives of Surgery, one of the JAMA/Archives journals."Healthcare-associated infections pose a significant burden to patients admitted following major injury," the authors write as background...

KETTERING, Ohio, March 15 /PRNewswire/ -- Kettering Health Network is the nation's first health system to use a new testing process developed by DIATHERIX Laboratories (www.DIATHERIX.com), which dramatically reduces the time it takes to detect H1N1, methicillin resistant staphylococcus (MRSA), Clostridium difficile (C-diff) and other infectious diseases. Kettering Medical Center (KMC) will be the first hospital in the network to use the testing system and DIATHERIX will maintain an onsite...